Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

N. van Zandwijk; E.F. Smit; G. Kramer; F.M. Schramel; S. Gans; J. Festen; A. Termeer; N.J.J. Schlösser; C. Debruyne; D. Curran; G. Giaccone

Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

Translated title of the contribution: Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

N. van Zandwijk, E.F. Smit, G. Kramer, F.M. Schramel, S. Gans, J. Festen, A. Termeer, N.J.J. Schlösser, C. Debruyne, D. Curran, G. Giaccone

Department of Pulmonary Diseases

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).
Original language	Undefined/Unknown
Pages (from-to)	2658-2664
Number of pages	7
Journal	Journal of Clinical Oncology
Volume	18
Issue number	14
Publication status	Published - 2000

Cite this

van Zandwijk, N., Smit, E. F., Kramer, G., Schramel, F. M., Gans, S., Festen, J., Termeer, A., Schlösser, N. J. J., Debruyne, C., Curran, D., & Giaccone, G. (2000). Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). Journal of Clinical Oncology, 18(14), 2658-2664.

van Zandwijk, N. ; Smit, E.F. ; Kramer, G. et al. / Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). In: Journal of Clinical Oncology. 2000 ; Vol. 18, No. 14. pp. 2658-2664.

@article{6bdd2438741f43ef96ed0f25245c6603,

title = "Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).",

author = "{van Zandwijk}, N. and E.F. Smit and G. Kramer and F.M. Schramel and S. Gans and J. Festen and A. Termeer and N.J.J. Schl{\"o}sser and C. Debruyne and D. Curran and G. Giaccone",

year = "2000",

language = "Undefined/Unknown",

volume = "18",

pages = "2658--2664",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "14",

}

van Zandwijk, N, Smit, EF, Kramer, G, Schramel, FM, Gans, S, Festen, J, Termeer, A, Schlösser, NJJ, Debruyne, C, Curran, D & Giaccone, G 2000, 'Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).', Journal of Clinical Oncology, vol. 18, no. 14, pp. 2658-2664.

Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). / van Zandwijk, N.; Smit, E.F.; Kramer, G. et al.
In: Journal of Clinical Oncology, Vol. 18, No. 14, 2000, p. 2658-2664.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

AU - van Zandwijk, N.

AU - Smit, E.F.

AU - Kramer, G.

AU - Schramel, F.M.

AU - Gans, S.

AU - Festen, J.

AU - Termeer, A.

AU - Schlösser, N.J.J.

AU - Debruyne, C.

AU - Curran, D.

AU - Giaccone, G.

PY - 2000

Y1 - 2000

M3 - Article

SN - 0732-183X

VL - 18

SP - 2658

EP - 2664

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 14

ER -

van Zandwijk N, Smit EF, Kramer G, Schramel FM, Gans S, Festen J et al. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). Journal of Clinical Oncology. 2000;18(14):2658-2664.